IL2 and type 2 diabetes mellitus: C-reactive protein levels were not affected by n-3 supplementation (3 g/day for eight weeks) in a randomized control trial for persons with type 2 diabetes; yet IL-2 and TNF-α, other indicators of inflammation, were reduced in the n-3 group [30].